TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
STOCKS

Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women

  • By Rob Daniel
  • Jun 24, 2019 4:19 PM EDT
PRESS RELEASES

Palatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment Conference

  • By PR Newswire
  • Sep 10, 2020 5:47 PM EDT
PRESS RELEASES

Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference

  • By PR Newswire
  • Aug 13, 2020 4:12 PM EDT
PRESS RELEASES

Palatin Technologies, Inc. Announces Completion Of Enrollment Of Phase 2 Study With PL9643 For The Treatment Of Dry Eye Disease

  • By PR Newswire
  • Aug 5, 2020 7:30 AM EDT
PRESS RELEASES

Palatin Technologies Announces Mutual Termination Of License Agreement With AMAG Pharmaceuticals For Vyleesi®

  • By PR Newswire
  • Jul 27, 2020 7:00 AM EDT
PRESS RELEASES

Palatin Technologies, Inc. Announces Reinitiation Of Enrollment Of Phase 2 Study With PL9643 For The Treatment Of Dry Eye Disease

  • By PR Newswire
  • Jul 8, 2020 7:30 AM EDT
PRESS RELEASES

Palatin Technologies To Develop PL8177 As A Potential Treatment For COVID-19 And Associated Lung Complications

  • By PR Newswire
  • Jun 23, 2020 7:30 AM EDT
PRESS RELEASES

Palatin Technologies Provides Assessment Of Impact Of COVID-19 Pandemic On Business Operations

  • By PR Newswire
  • Apr 30, 2020 7:30 AM EDT
PRESS RELEASES

Palatin Technologies, Inc. Announces First Patient Enrolled In Dry Eye Disease Phase 2 Clinical Trial With PL9643

  • By PR Newswire
  • Feb 19, 2020 7:30 AM EST
PRESS RELEASES

Palatin Provides Corporate Update And 2020 Calendar Outlook

  • By PR Newswire
  • Jan 21, 2020 7:30 AM EST
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
STOCKS

Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women

  • By Rob Daniel
  • Jun 24, 2019 4:19 PM EDT
Here's Why These 7 Companies Have the Best Self-Driving Car Programs
STOCKS

How to trade today's most active stocks: Ford, Palatin, more

  • By Jonas Elmerraji
  • Nov 2, 2016 12:44 PM EDT
Inovio Stock Rises on Positive Results From Ebola Vaccine Tests
STOCKS

Palatin female libido-boosting shot fails crucial sex frequency test

  • By Adam Feuerstein
  • Nov 2, 2016 7:20 AM EDT
New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

  • By TheStreet Wire
  • Oct 6, 2015 10:45 AM EDT
Pinnacle Entertainment (PNK) Stock Advances Despite Q2 Miss
MARKETS

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

  • By Tony Owusu
  • Aug 20, 2015 2:18 PM EDT
Sina Stock Falls in After-Hours Trading After Reporting Q1 Results
MARKETS

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

  • By Tony Owusu
  • Aug 19, 2015 2:20 PM EDT
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Palatin Technologies (PTN) Strong On High Relative Volume Today

  • By TheStreet Wire
  • Jun 8, 2015 10:04 AM EDT
What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment

  • By Tony Owusu
  • Jun 5, 2015 12:31 PM EDT
Chicago Mercantile Exchange Is Sizzling, Here's What to Expect
INVESTING

3 Stocks Under $10 to Trade for Breakouts

  • By Roberto Pedone
  • Apr 21, 2015 1:34 PM EDT
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Aug 27, 2014 4:31 PM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Biotech Stock Mailbag: Amarin, MannKind, Palatin

  • By Adam Feuerstein
  • May 24, 2013 7:00 AM EDT
5 Stocks Insiders Love Right Now
INVESTING

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Oct 26, 2012 1:24 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Sep 11, 2012 2:50 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript

  • By Seeking Alpha
  • May 14, 2012 4:48 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Feb 15, 2012 2:15 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.